272 related articles for article (PubMed ID: 24852474)
41. Mohs appropriate use criteria: retrospectively applied to nonmelanoma skin cancers at a single academic center.
Chong T; Tristani-Firouzi P; Bowen GM; Hadley ML; Duffy KL
Dermatol Surg; 2015 Aug; 41(8):889-95. PubMed ID: 26066619
[TBL] [Abstract][Full Text] [Related]
42. Clinical value of paraffin sections in association with Mohs micrographic surgery for nonmelanoma skin cancers.
Ebede TL; Lee EH; Dusza SW; Busam KJ; Nehal KS
Dermatol Surg; 2012 Oct; 38(10):1631-8. PubMed ID: 22958072
[TBL] [Abstract][Full Text] [Related]
43. Skin cancer: a review with consideration of treatment options including Mohs micrographic surgery.
Lambert DR; Siegle RJ
Ohio Med; 1990 Oct; 86(10):745-7. PubMed ID: 2234766
[TBL] [Abstract][Full Text] [Related]
44. Incompletely excised basal cell carcinoma: residual tumor rates at Mohs re-excision.
Palmer VM; Wilson PR
Dermatol Surg; 2013 May; 39(5):706-18. PubMed ID: 23294110
[TBL] [Abstract][Full Text] [Related]
45. Efficacy of photodynamic diagnosis-guided Mohs micrographic surgery in primary squamous cell carcinoma.
Jeon SY; Kim KH; Song KH
Dermatol Surg; 2013 Dec; 39(12):1774-83. PubMed ID: 24299572
[TBL] [Abstract][Full Text] [Related]
46. Mohs micrographic surgery for basal cell carcinoma: evaluation of the indication criteria and predictive factors for extensive subclinical spread.
Hoorens I; Batteauw A; Van Maele G; Lapiere K; Boone B; Ongenae K
Br J Dermatol; 2016 Apr; 174(4):847-52. PubMed ID: 26595159
[TBL] [Abstract][Full Text] [Related]
47. Factors affecting choice of repair in Mohs micrographic surgery for non-melanoma skin cancer of the head.
Thomas CL; Lam A; Lam J; Paver R; Storey L; Fernandez-Peñas P
Australas J Dermatol; 2017 Aug; 58(3):189-193. PubMed ID: 26914474
[TBL] [Abstract][Full Text] [Related]
48. Difference between pigmented and nonpigmented basal cell carcinoma treated with Mohs micrographic surgery.
Aoyagi S; Nouri K
Dermatol Surg; 2006 Nov; 32(11):1375-9. PubMed ID: 17083591
[TBL] [Abstract][Full Text] [Related]
49. Basal cell carcinoma treated with Mohs surgery in Australia III. Perineural invasion.
Leibovitch I; Huilgol SC; Selva D; Richards S; Paver R
J Am Acad Dermatol; 2005 Sep; 53(3):458-63. PubMed ID: 16112353
[TBL] [Abstract][Full Text] [Related]
50. Duplicitous growth of infiltrative basal cell carcinoma: Analysis of clinically undetected tumor extent in a paired case-control study.
Hendrix JD; Parlette HL
Dermatol Surg; 1996 Jun; 22(6):535-9. PubMed ID: 8646468
[TBL] [Abstract][Full Text] [Related]
51. Conservative thickness layers in Mohs micrographic surgery.
Tolkachjov SN; Cappel JA; Bryant EA; Harmon CB
Int J Dermatol; 2018 Sep; 57(9):1128-1134. PubMed ID: 29774540
[TBL] [Abstract][Full Text] [Related]
52. Appropriate use criteria for basal cell carcinoma Mohs surgery at a single center in the face of high-burden skin cancer: a retrospective cohort study.
Fantini BC; Bueno Filho R; Chahud F; Souza CDS
J Dermatolog Treat; 2019 Feb; 30(1):74-80. PubMed ID: 29727201
[TBL] [Abstract][Full Text] [Related]
53. Mohs micrographic surgery vs traditional surgical excision: a cost comparison analysis.
Bialy TL; Whalen J; Veledar E; Lafreniere D; Spiro J; Chartier T; Chen SC
Arch Dermatol; 2004 Jun; 140(6):736-42. PubMed ID: 15210467
[TBL] [Abstract][Full Text] [Related]
54. Characteristics of basal cell carcinoma of the lip treated using Mohs micrographic surgery.
Lee KC; Higgins HW; Cruz AP; Dufresne RG
Dermatol Surg; 2012 Dec; 38(12):1956-61. PubMed ID: 22989078
[TBL] [Abstract][Full Text] [Related]
55. Mohs micrographic surgery for basal cell carcinomas: appropriateness of 'Rotterdam' criteria and predictive factors for three or more stages.
Flohil SC; van Dorst AM; Nijsten T; Martino Neumann HA; Munte K
J Eur Acad Dermatol Venereol; 2013 Oct; 27(10):1228-35. PubMed ID: 23039378
[TBL] [Abstract][Full Text] [Related]
56. The Australian Mohs database: short-term recipient-site complications in full-thickness skin grafts.
Leibovitch I; Huilgol SC; Richards S; Paver R; Selva D
Dermatol Surg; 2006 Nov; 32(11):1364-8. PubMed ID: 17083589
[TBL] [Abstract][Full Text] [Related]
57. Microcystic adnexal carcinoma: treatment with Mohs micrographic surgery.
Leibovitch I; Huilgol SC; Selva D; Lun K; Richards S; Paver R
J Am Acad Dermatol; 2005 Feb; 52(2):295-300. PubMed ID: 15692477
[TBL] [Abstract][Full Text] [Related]
58. Mohs Micrographic Surgery in Patients Younger Than 40 Years.
Stewart TJ; Venning VL; Moreno Bonilla G; Byth K; Lee S; Fernandez-Penas P
Dermatol Surg; 2020 Dec; 46(12):1481-1485. PubMed ID: 32141929
[TBL] [Abstract][Full Text] [Related]
59. Cost effectiveness of Mohs micrographic surgery: review of the literature.
Tierney EP; Hanke CW
J Drugs Dermatol; 2009 Oct; 8(10):914-22. PubMed ID: 19852120
[TBL] [Abstract][Full Text] [Related]
60. A randomized controlled trial of high-viscosity 2-octyl cyanoacrylate tissue adhesive versus sutures in repairing facial wounds following Mohs micrographic surgery.
Sniezek PJ; Walling HW; DeBloom JR; Messingham MJ; VanBeek MJ; Kreiter CD; Whitaker DC; Arpey CJ
Dermatol Surg; 2007 Aug; 33(8):966-71. PubMed ID: 17661940
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
